tiprankstipranks
Advertisement
Advertisement

GILD Stock Latest News

Galapagos, Gilead enter pact to collaborate on T cell engager therapies
The FlyGalapagos, Gilead enter pact to collaborate on T cell engager therapies
14h ago
GILD
GLPG
Clear Street says Gilead-Ouro deal highlights upside for Cullinan’s velinotamig
PremiumThe Fly
Clear Street says Gilead-Ouro deal highlights upside for Cullinan’s velinotamig
7d ago
CGEM
GILD
Galapagos in partnership discussions with Gilead after Ouro deal
PremiumThe Fly
Galapagos in partnership discussions with Gilead after Ouro deal
8d ago
GILD
GLPG
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
PremiumMarket News
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
8d ago
GSK
GILD
Gilead to acquire Ouro Medicines
PremiumThe Fly
Gilead to acquire Ouro Medicines
8d ago
GILD
Gilead to acquire Ouro Medicines for $1.675B
PremiumThe FlyGilead to acquire Ouro Medicines for $1.675B
8d ago
GILD
Gilead near acquisition of Ouro Medicines for up to $2B, FT reports
Premium
The Fly
Gilead near acquisition of Ouro Medicines for up to $2B, FT reports
8d ago
GILD
Gilead near deal to buy Ouro Medicines for up to $2B, FT reports
Premium
The Fly
Gilead near deal to buy Ouro Medicines for up to $2B, FT reports
8d ago
GILD
Buy Rating on Gilead Driven by HIV Franchise Momentum and Upside from Yeztugo and Biktarvy
PremiumRatings
Buy Rating on Gilead Driven by HIV Franchise Momentum and Upside from Yeztugo and Biktarvy
9d ago
GILD
Gilead Ends Obeldesivir Filovirus Prophylaxis Trial: What It Means for GILD Investors
PremiumCompany Announcements
Gilead Ends Obeldesivir Filovirus Prophylaxis Trial: What It Means for GILD Investors
11d ago
GILD
3 Best ETFs to Invest In, According to AI Analyst, 03/10/2026
PremiumMarket News
3 Best ETFs to Invest In, According to AI Analyst, 03/10/2026
21d ago
JNJ
MRK
Gilead initiated with a Buy at Jefferies
PremiumThe Fly
Gilead initiated with a Buy at Jefferies
22d ago
GILD
The Week That Was, The Week Ahead: Macro and Markets, Mar. 8
PremiumMarket NewsThe Week That Was, The Week Ahead: Macro and Markets, Mar. 8
24d ago
AA
DG
Gilead Sciences: Advancing Long-Acting HIV Franchise Underscores Competitive Edge and Supports Buy Rating
Premium
Ratings
Gilead Sciences: Advancing Long-Acting HIV Franchise Underscores Competitive Edge and Supports Buy Rating
1M ago
GILD
Gilead presents new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data
Premium
The Fly
Gilead presents new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data
1M ago
GILD
Gilead: Strategic Arcellx Acquisition and Anito-cel Pipeline Strength Underpin Buy Rating and $162 Target
PremiumRatings
Gilead: Strategic Arcellx Acquisition and Anito-cel Pipeline Strength Underpin Buy Rating and $162 Target
1M ago
GILD
Qualcomm, Booking Holdings upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Qualcomm, Booking Holdings upgraded: Wall Street’s top analyst calls
1M ago
BE
DPZ
Arcellx downgraded to Hold from Buy at Stifel
PremiumThe Fly
Arcellx downgraded to Hold from Buy at Stifel
1M ago
ACLX
GILD
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
1M ago
AMC
AMD
Arcellx Stock (ACLX) Rockets on a Massive Deal with Gilead Sciences (GILD)
PremiumMarket NewsArcellx Stock (ACLX) Rockets on a Massive Deal with Gilead Sciences (GILD)
1M ago
ACLX
GILD
Midday Fly By: Trump ups worldwide tariff to 15%, Gilead buying Arcellx
Premium
The Fly
Midday Fly By: Trump ups worldwide tariff to 15%, Gilead buying Arcellx
1M ago
D
DE
Alphabet, Nvidia upgraded: Wall Street’s top analyst calls
Premium
The Fly
Alphabet, Nvidia upgraded: Wall Street’s top analyst calls
1M ago
DE
BLK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >